ARTICLE | Clinical News
Thymitaq nolatrexed: Phase III
February 2, 2004 8:00 AM UTC
Eximias said an independent data safety monitoring board (DSMB) unanimously recommended that the international Phase III (ETHECC) liver cancer trial continue. Eximias said the DSMB reviewed safety dat...